Epirubicin and pneumonitis Patient Reports February 12, 2012

Epirubicin Side Effects Report #5277937-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 15, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, candida serology positive, febrile neutropenia, pneumonitis, pneumothorax, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE. Patient died.

Epirubicin Side Effects Report #5318206-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 25, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: pneumonitis, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE. Patient died.

Epirubicin Side Effects Report #5377622-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, candida serology positive, febrile neutropenia, fungus sputum test positive, pneumonitis, respiratory failure, streptococcal infection . Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient died.

Epirubicin Side Effects Report #5395845-8
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.


Epirubicin Side Effects Report #5407559-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood culture positive, candidiasis, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5651720-2
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 22, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5704744-0
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood culture positive, candida serology positive, febrile neutropenia, mucosal inflammation, pneumonitis, respiratory failure, stridor. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE, DEXAMETHASONE, CILASTATIN, IMIPENEM. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5727855-2
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 23, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.